DR. GERALD S LIPSHUTZ MD
NPI 1649205543
Transplant Surgery in Los Angeles, CA

Active since July 11, 2006PECOS EnrolledAccepts Medicare Assignment
94.77/100
CMS Quality Rating
200 UCLA MEDICAL PLZ STE 214, LOS ANGELES, CA 90095(310) 794-7788(310) 206-4197 Get Directions Write a Review

NPPES record last updated: December 30, 2019. Verified against the NPPES registry weekly; last sync: July 19, 2026.

About Dr. Gerald S Lipshutz Md NPPES

Official registry information on file with the National Plan and Provider Enumeration System.

DR. GERALD S LIPSHUTZ MD (NPI 1649205543) is an individual transplant surgery provider in Los Angeles, California, licensed in California (G81326) and active in the NPI registry since July 2006. He is enrolled in Medicare PECOS and is a graduate of University Of California, Geffen School Of Medicine (1993).

NPPES Registry Identity

NPI1649205543
Entity TypeIndividualMale
Primary Taxonomy204F00000X
Provider Legal NameDR. GERALD S LIPSHUTZCredential: MD
Location Address200 UCLA MEDICAL PLZ STE 214Los Angeles, CA 90095-8344
Mailing Address5767 W Century Blvd Ste 400Los Angeles, CA 90045-5631
Fax(310) 206-4197
Sole ProprietorNo
Medical School CMSUniversity Of California, Geffen School Of MedicineGraduated 1993
Enumeration DateJuly 11, 2006
Last NPPES UpdateDecember 30, 2019
NPI 1649205543 is a valid, active identifier and passes the ISO check-digit test.

Specialties & Licenses 2

Primary SpecialtyTransplant SurgeryAllopathic & Osteopathic Physicians
Taxonomy Code204F00000X
License Licensed in CA · G81326
Definition

A surgeon who specializes in transplant surgery. Source: National Uniform Claim Committee

Also ListedUrologyTaxonomy 208800000X · License G81326 (CA)
200 UCLA MEDICAL PLZ STE 214, Los Angeles, CA 90095

Other Identifiers 1

Medicaid00G813260CA

Medicare Participation & PECOS CMS

Medicare enrollment, assignment, and ordering and referring status from the CMS PECOS system.

Medicare Enrollment Status

Enrolled in Medicare and accepts Medicare assignment

Dr. Gerald S Lipshutz Md is registered in PECOS and agrees to accept the Medicare-approved amount as full payment. Medicare patients are not billed beyond the standard deductible and coinsurance.

PECOS PAC ID8224004064
PECOS Enrollment IDI20040902001403
Eligible to Order & Refer Part B Labs & Imaging Durable Medical Equipment Home Health Agency Power Mobility DevicesPer the CMS Ordering and Referring file. Eligibility means Medicare pays claims that this provider orders or refers for these categories.

Medicare Quality Performance CMS QPP · MIPS

Performance in the CMS Quality Payment Program: the MIPS final score across four weighted categories, and the individual quality measures reported to Medicare.

94.77/100
MIPS Final ScoreMerit-based Incentive Payment System · CMS Quality Payment Program
Scored as part of a group practice
Quality61.65
Promoting Interoperability100
Improvement Activities40
Cost87.6

Referred Medical Equipment & Supplies CMS DME claims 6

Durable medical equipment, devices and supplies this provider ordered from DME suppliers for patients, from Medicare fee-for-service claims.

Tacrolimus, immediate release, oral, 1 mg J7507
Treatment-Treatment - Miscellaneous · category RX029N
6 suppliers62 claims9,420 services$0.30 avg. paid by Medicare
Prednisone, immediate release or delayed release, oral, 1 mg J7512
Treatment-Treatment - Miscellaneous · category RX029N
4 suppliers25 claims3,660 services$0.01 avg. paid by Medicare
Mycophenolate mofetil, oral, 250 mg J7517
Treatment-Treatment - Miscellaneous · category RX029N
2 suppliers19 claims1,620 services$0.19 avg. paid by Medicare
Mycophenolic acid, oral, 180 mg J7518
Treatment-Treatment - Miscellaneous · category RX029N
1 supplier11 claims1,320 services$1.01 avg. paid by Medicare
Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period Q0511
Treatment-Chemotherapy · category RH012N
6 suppliers55 claims55 services$17.22 avg. paid by Medicare
Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period Q0512
Treatment-Chemotherapy · category RH012N
7 suppliers65 claims68 services$12.27 avg. paid by Medicare
Dollar amounts are the average Medicare paid the supplier per service. They are not the cost to the patient.

Other Providers at the Same Location NPPES 20

Providers registered at the same practice address, or within the immediate area, according to the NPPES registry.

Surgery (Surgical Critical Care)
200 UCLA MEDICAL PLZ STE 214
LOS ANGELES, CA 90095
Transplant Surgery
200 UCLA MEDICAL PLZ STE 214
LOS ANGELES, CA 90095
Transplant Surgery
200 UCLA MEDICAL PLZ STE 214
LOS ANGELES, CA 90095
Surgery (Surgical Oncology)
200 UCLA MEDICAL PLZ STE 214
LOS ANGELES, CA 90095
Surgery
200 UCLA MEDICAL PLZ STE 214
LOS ANGELES, CA 90095
Surgery
200 UCLA MEDICAL PLZ STE 214
LOS ANGELES, CA 90095
Surgery
200 UCLA MEDICAL PLZ STE 214
LOS ANGELES, CA 90095
Colon & Rectal Surgery
200 UCLA MEDICAL PLZ STE 214
LOS ANGELES, CA 90095

Frequently Asked Questions NPPES & CMS

Common questions about this NPI record, answered from the official NPPES registry and CMS datasets shown on this page.

What is Gerald Lipshutz's NPI number?

The NPI number for Gerald Lipshutz is 1649205543. It was assigned to this individual provider in the NPPES registry on July 11, 2006.

Where is Gerald Lipshutz located?

Gerald Lipshutz practices at 200 Ucla Medical Plz Ste 214, Los Angeles, CA 90095. The listed phone number is (310) 794-7788.

What is Gerald Lipshutz's specialty?

The primary specialty registered for this NPI is Transplant Surgery with taxonomy code 204F00000X.

Is Gerald Lipshutz enrolled in Medicare?

Yes. Gerald Lipshutz is registered in the Medicare PECOS system and accepts Medicare assignment, which means accepting the Medicare-approved amount as payment in full for covered services.

When was this NPI record last updated?

The NPPES record for Gerald Lipshutz was last updated on December 30, 2019. NPI Profile syncs with the weekly NPPES data releases published by CMS.